Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myeloid, Acute 2Lymphoma, Follicular 1Lymphoma 1Leukemia 1Cognitive Dysfunction 1Brain Neoplasms 1Brain Injuries, Traumatic 1Attention Deficit Disorder with Hyperactivity 1Anxiety Disorders 1

Interventions

Cyclophosphamide 260fludarabine phosphate 163Methotrexate 124Rituximab 112Cytarabine 109Filgrastim 106fludarabine 92Busulfan 86Peripheral Blood Stem Cell Transplantation 83Etoposide 82Vincristine 80Radiotherapy 79Tacrolimus 73Mycophenolic Acid 72Antilymphocyte Serum 68Whole-Body Irradiation 66Melphalan 63Dexamethasone 63Cyclosporine 58Doxorubicin 51Prednisone 44Methylprednisolone 44Alemtuzumab 44Mercaptopurine 41Granulocyte Colony-Stimulating Factor 40pegaspargase 35Daunorubicin 34Clofarabine 33Thiotepa 31Asparaginase 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia × Control Groups × Lymphoid × Clear all
NCT00498719 2020-12-31

Cognitive Training in Attenuating Attention Deficits/Child Treatment for Cancer

M.D. Anderson Cancer Center

Unknown
30 enrolled
CNSLymphoidOther hematologic neoplasm

Attention Deficit Disorder with Hyperactivity, Brain Neoplasms, Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡